ArticleEClinicalMedicine2025

Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.

Jiacheng Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.